US approves Merck’s Ebola vaccine
The approval marks a “significant milestone in Ebola prepardness and prevention”
Read More
Tag: BARDA
Enesi and BARDA to co-develop flu vaccines
The public-private partnership aims to provide a cost-effective technological innovation.
Read More
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
